Li et al. [79] found that TOPK was significantly upregulated and profoundly activated in lung cancer cells that exhibited resistance to EGFR-TKIs, which phosphorylated c-Jun, leading to an increased level of AP-1 [80]. The gene discussed is EGFR; the disease is lung carcinoma.